The Annual Meeting of the ASMBS is its premier scientific meeting. It enhances attendees’ professional and scientific education in bariatric surgery and the care of the bariatric surgical patient. The ASMBS reserves the right to control all aspects of the conduct of the Annual Meeting. The ASMBS specifically reserves the right to determine the acceptability of applications for exhibit space. All applications must meet the following criteria:
The products or services to be exhibited are of professional or educational interest or benefit to the attendees and are, in the opinion of the ASMBS, related to the field of bariatric surgery.
The applicant’s goods or services to be exhibited are considered by the ASMBS to be consistent with the ASMBS’s scientific or public policies, positions, statements or guidelines. This also includes the parent or subsidiary corporation of the applicant or goods and services thereof, which must also be deemed by the ASMBS to be consistent with the ASMBS’s scientific or public policies, positions, statements or guidelines.
The applicant is reasonably determined by the ASMBS to be highly ethical and reputable, and the goods and services to be exhibited are reasonably believed by the ASMBS not to be harmful, illegal, ineffective, fraudulent or based on non-proven science.
The applicant agrees to comply with the ASMBS rules and regulations governing the Annual Meeting.
The application and required documents must be completely and accurately filled out. The parent and subsidiary corporations of the applicant must be identified in the appropriate section of the application form, with an indication of their primary products or services. All products and/or services to be exhibited must be listed on the application for exhibit space.
Only products or services listed on the original application and approved by ASMBS may be exhibited.
The application and required documents must be received prior to the established deadlines.
Applications may be refused or booth space restricted due to space limitations or other reasons determined by the ASMBS. Incomplete applications will not be processed.
Upon submitting an application for exhibit space, the exhibitor agrees that the information contained in this Prospectus and the ASMBS Rules and Regulations are an integral and binding part of the exhibit space contract and that it is the responsibility of the exhibiting company to distribute information to ensure that all individuals staffing the booth are aware of the rules and regulations governing the Annual Meeting.
All products and services must meet FDA guidelines and standards or be FDA-approved. Products in the pre-approved stages must be specified on the original application/contract. Exhibitors will be required to submit in writing, approval from the FDA to exhibit the products in the current stage of approval.
Failure of an exhibiting company to notify the ASMBS, prior to the Annual Meeting, of the FDA status of products is a violation of regulations and will result in the loss of Priority Points. The ASMBS reserves the right to close exhibits or parts of exhibits if notification of FDA status is not provided prior to the Annual Meeting.
Exhibitors shall comply with all applicable U.S. Food and Drug Administration (FDA) regulations, including, without limitation, FDA restrictions on the promotion of investigational and pre-approved drugs and devices and the FDA prohibition on promoting approved drugs and devices for unapproved uses. Any product not
FDA-approved for a particular use or not commercially available in the U.S. may be exhibited only if accompanied by easily visible signs indicating the status of the product. Exhibitors shall have available at their exhibit space a letter from the FDA that describes the allowable use of any drug or device exhibited.
This sign, simply stated, shall read “(product) made by (company) has not been approved by the U.S. Food & Drug Administration.”